Recruiting NA Sciatica Due to Intervertebral Disc Disorder

New treatment option for Sciatica Due to Intervertebral Disc Disorder

Official title Two-leg Rotation and Sciatica

ClinicalTrials.gov ID: NCT07444125

What this study is testing

What it's testing
this study including the application of a specific technique of Mulligan mobilization calles 2 leg rotation on patients having lumbar discogenic lesion with sciatica. this technique is designed to address sciatic pain and proposed to reduce sciatica by opening the intervertebral foramnia.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 to 50

You may be able to join if

  • Both genders.
  • Age between 18 and 50
  • Have lumbar discogenic lesions.
  • Having sciatica symptoms extending down to the knee.

You likely can't join if

  • Surgical operation in the lumbar spine
  • Severe discogenic lesions with bladder or fecal incontinence or progressive muscular weakness.
  • Piriform syndrome.

The study team makes the final eligibility decision.

Where it's taking place

  • Ha'il, Ha'il Region, Saudi Arabia

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Ha'il, Ha'il Region, Saudi Arabia. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.